
William A. Craigo
Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 936 |
| Issued Applications | 383 |
| Pending Applications | 126 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19186121
[patent_doc_number] => 20240165034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
[patent_app_type] => utility
[patent_app_number] => 18/409041
[patent_app_country] => US
[patent_app_date] => 2024-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18409041
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/409041 | MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) | Jan 9, 2024 | Abandoned |
Array
(
[id] => 19297400
[patent_doc_number] => 20240225965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => Lipstick Use And Application
[patent_app_type] => utility
[patent_app_number] => 18/407573
[patent_app_country] => US
[patent_app_date] => 2024-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18407573
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/407573 | Lipstick Use And Application | Jan 8, 2024 | Pending |
Array
(
[id] => 19297575
[patent_doc_number] => 20240226140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => NITRIC OXIDE AND MOLECULAR HYDROGEN GENERATING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/405865
[patent_app_country] => US
[patent_app_date] => 2024-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9781
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18405865
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/405865 | NITRIC OXIDE AND MOLECULAR HYDROGEN GENERATING COMPOSITIONS | Jan 4, 2024 | Pending |
Array
(
[id] => 19641492
[patent_doc_number] => 20240416012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => Device with Microstructure Mediated Absorption Profile
[patent_app_type] => utility
[patent_app_number] => 18/402014
[patent_app_country] => US
[patent_app_date] => 2024-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18402014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/402014 | Device with Microstructure Mediated Absorption Profile | Jan 1, 2024 | Pending |
Array
(
[id] => 19343395
[patent_doc_number] => 20240252358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => PREPARATION OF OCCLUSIVE DRESSINGS
[patent_app_type] => utility
[patent_app_number] => 18/400548
[patent_app_country] => US
[patent_app_date] => 2023-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18400548
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/400548 | PREPARATION OF OCCLUSIVE DRESSINGS | Dec 28, 2023 | Pending |
Array
(
[id] => 19387832
[patent_doc_number] => 20240277702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => INJECTABLE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/541083
[patent_app_country] => US
[patent_app_date] => 2023-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18541083
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/541083 | INJECTABLE FORMULATION | Dec 14, 2023 | Abandoned |
Array
(
[id] => 19081775
[patent_doc_number] => 20240108576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => COMPOSITIONS FOR ORAL MUCOADHESIVE DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 18/538991
[patent_app_country] => US
[patent_app_date] => 2023-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18538991
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/538991 | COMPOSITIONS FOR ORAL MUCOADHESIVE DOSAGE FORMS | Dec 12, 2023 | Abandoned |
Array
(
[id] => 19111375
[patent_doc_number] => 20240123125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL
[patent_app_type] => utility
[patent_app_number] => 18/537725
[patent_app_country] => US
[patent_app_date] => 2023-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18537725
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/537725 | ENDOSCOPIC SUBMUCOSAL INJECTION MATERIAL | Dec 11, 2023 | Pending |
Array
(
[id] => 19232284
[patent_doc_number] => 20240189476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => PHOTO-CROSSLINKABLE PLANT-BASED MATERIALS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/535288
[patent_app_country] => US
[patent_app_date] => 2023-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18535288
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/535288 | PHOTO-CROSSLINKABLE PLANT-BASED MATERIALS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME | Dec 10, 2023 | Pending |
Array
(
[id] => 19032353
[patent_doc_number] => 20240082168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => CONTROLLED DRUG RELEASE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/389206
[patent_app_country] => US
[patent_app_date] => 2023-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18389206
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/389206 | CONTROLLED DRUG RELEASE FORMULATION | Nov 12, 2023 | Abandoned |
Array
(
[id] => 19018923
[patent_doc_number] => 20240075094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => Low-Dose Stable Formulations of Linaclotide
[patent_app_type] => utility
[patent_app_number] => 18/505414
[patent_app_country] => US
[patent_app_date] => 2023-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18505414
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/505414 | Low-Dose Stable Formulations of Linaclotide | Nov 8, 2023 | Abandoned |
Array
(
[id] => 19280039
[patent_doc_number] => 20240216512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION
[patent_app_type] => utility
[patent_app_number] => 18/386522
[patent_app_country] => US
[patent_app_date] => 2023-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18386522
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/386522 | INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION | Nov 1, 2023 | Abandoned |
Array
(
[id] => 19170670
[patent_doc_number] => 20240156644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => BUFFERED ADHESIVE COMPOSITIONS FOR SKIN-ADHERING MEDICAL PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/381401
[patent_app_country] => US
[patent_app_date] => 2023-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18381401
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/381401 | BUFFERED ADHESIVE COMPOSITIONS FOR SKIN-ADHERING MEDICAL PRODUCTS | Oct 17, 2023 | Pending |
Array
(
[id] => 19860805
[patent_doc_number] => 20250099591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => CARRIER FOR PROMOTING FENTON REACTION AND PREPARATION PROCESS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/380674
[patent_app_country] => US
[patent_app_date] => 2023-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18380674
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/380674 | CARRIER FOR PROMOTING FENTON REACTION AND PREPARATION PROCESS AND USES THEREOF | Oct 16, 2023 | Pending |
Array
(
[id] => 18877334
[patent_doc_number] => 20240000703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
[patent_app_type] => utility
[patent_app_number] => 18/468542
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18468542
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/468542 | Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue | Sep 14, 2023 | Issued |
Array
(
[id] => 19839087
[patent_doc_number] => 12251443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Drug formulations comprising polyoxazolines as matrix excipient
[patent_app_type] => utility
[patent_app_number] => 18/467916
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 7986
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18467916
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/467916 | Drug formulations comprising polyoxazolines as matrix excipient | Sep 14, 2023 | Issued |
Array
(
[id] => 19280114
[patent_doc_number] => 20240216587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => Multi-Layered Graft for Tissue Engineering Applications
[patent_app_type] => utility
[patent_app_number] => 18/244351
[patent_app_country] => US
[patent_app_date] => 2023-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18244351
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/244351 | Multi-layered graft for tissue engineering applications | Sep 10, 2023 | Issued |
Array
(
[id] => 20606967
[patent_doc_number] => 12582546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Methods and devices for controlled delivery
[patent_app_type] => utility
[patent_app_number] => 18/236109
[patent_app_country] => US
[patent_app_date] => 2023-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 24784
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 539
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18236109
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/236109 | Methods and devices for controlled delivery | Aug 20, 2023 | Issued |
Array
(
[id] => 18815621
[patent_doc_number] => 20230389959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => Methods and Devices for Conduit Occlusion
[patent_app_type] => utility
[patent_app_number] => 18/233143
[patent_app_country] => US
[patent_app_date] => 2023-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18233143
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/233143 | Methods and Devices for Conduit Occlusion | Aug 10, 2023 | Pending |
Array
(
[id] => 19751980
[patent_doc_number] => 20250040545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => USE OF SYNERGISTIC COMPOSITIONS BASED ON ZOXAMIDE AND CYFLUFENAMID AS FUNGICIDES IN THE AGRONOMIC FIELD
[patent_app_type] => utility
[patent_app_number] => 18/230488
[patent_app_country] => US
[patent_app_date] => 2023-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18230488
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/230488 | USE OF SYNERGISTIC COMPOSITIONS BASED ON ZOXAMIDE AND CYFLUFENAMID AS FUNGICIDES IN THE AGRONOMIC FIELD | Aug 3, 2023 | Pending |